Gaëlle Preiss
Director - Regulatory Science at Voisin Consulting Life Sciences (VCLS)- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Effective Listening
LinkedInJul, 2020- Nov, 2024
Experience
-
Voisin Consulting Life Sciences (VCLS)
-
France
-
Biotechnology Research
-
100 - 200 Employee
-
Director - Regulatory Science
-
Jan 2022 - Present
-
-
Associate Director - Regulatory Science
-
Jan 2021 - Feb 2022
-
-
Senior Regulatory Scientist
-
Apr 2016 - Jan 2021
-
-
-
Alexion Pharmaceuticals, Inc.
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Regulatory Affairs Manager - International Registration
-
Mar 2013 - Jan 2016
- Define and implement strategies for regulatory submissions for obtaining MA and maintaining (variations, renewals) approvals for Orphan products in International markets including Asia, Middle East Africa and Canada - Ensure that the pharmaceutical products distributed in those countries meet the local regulatory requirements and support the local sales and marketing organization - Ensure that pharmacovigilance obligations are met in the territories covered by the business -… Show more - Define and implement strategies for regulatory submissions for obtaining MA and maintaining (variations, renewals) approvals for Orphan products in International markets including Asia, Middle East Africa and Canada - Ensure that the pharmaceutical products distributed in those countries meet the local regulatory requirements and support the local sales and marketing organization - Ensure that pharmacovigilance obligations are met in the territories covered by the business - Responsible for coordinating all aspects of regulatory submissions for clinical trials (CTA), Orphan Drug Designation procedures in International markets
-
-
Regulatory Affairs Manager
-
Dec 2009 - Feb 2013
Clinical Development: - Conduct of Regulatory Assessment during Due Diligence and acquisition process - Provide regulatory support and strategic advice to senior management, project teams, key internal/external customers - Elaboration of the Regulatory Strategy for Registration in collaboration with CMC, Pre-clinical and Clinical teams - Regulatory expertise on Name Patient Programs - Review of clinical documentation (protocols, amendment) - Writing of IMPDs -… Show more Clinical Development: - Conduct of Regulatory Assessment during Due Diligence and acquisition process - Provide regulatory support and strategic advice to senior management, project teams, key internal/external customers - Elaboration of the Regulatory Strategy for Registration in collaboration with CMC, Pre-clinical and Clinical teams - Regulatory expertise on Name Patient Programs - Review of clinical documentation (protocols, amendment) - Writing of IMPDs - Coordination and submission of clinical trial applications in EMEA countries - Coordination and submission of answer to questions from Competent authorities (including writing of the documentation) - Communications/Negotiations with National Agencies - Communications/Negotiations with External Vendors - Set up the appropriate archiving process for Regulatory documentation related to Clinical Trials - Pharmacovigilance (Regulatory expertise, ASR, DSUR) - Participation in the Annual update of the Investigators Brochure - Development, implementation and training of relevant Clinical Trial SOPs. Paediatric Regulation : - Provide regulatory expertise and strategic advice to senior management, project teams - Writing, preparation and submission of Paediatric Investigation Plan, Compliance Check and Paediatric Annual Reports - Communications/Negotiations with EMA Pediatric Group
-
-
-
Servier
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Regulatory Affairs Manager
-
2006 - 2009
Clinical Development: -Review of clinical documentation (protocols, amendments, IMPDs) -Coordination and submission of clinical trial applications, amendments for international multicentres studies (phase I to III) (cardiovascular area) -Answers to questions from Competent Authorities -Pharmacovigilance (expedited and periodic reportings) Paediatric Regulation: -Regulatory intelligence on Paediatric regulation (EU and US) - Performed presentations on Pediatric… Show more Clinical Development: -Review of clinical documentation (protocols, amendments, IMPDs) -Coordination and submission of clinical trial applications, amendments for international multicentres studies (phase I to III) (cardiovascular area) -Answers to questions from Competent Authorities -Pharmacovigilance (expedited and periodic reportings) Paediatric Regulation: -Regulatory intelligence on Paediatric regulation (EU and US) - Performed presentations on Pediatric Regulation in various internal meetings - Writing, review and submission of Paediatric Investigation Plans Show less Clinical Development: -Review of clinical documentation (protocols, amendments, IMPDs) -Coordination and submission of clinical trial applications, amendments for international multicentres studies (phase I to III) (cardiovascular area) -Answers to questions from Competent Authorities -Pharmacovigilance (expedited and periodic reportings) Paediatric Regulation: -Regulatory intelligence on Paediatric regulation (EU and US) - Performed presentations on Pediatric… Show more Clinical Development: -Review of clinical documentation (protocols, amendments, IMPDs) -Coordination and submission of clinical trial applications, amendments for international multicentres studies (phase I to III) (cardiovascular area) -Answers to questions from Competent Authorities -Pharmacovigilance (expedited and periodic reportings) Paediatric Regulation: -Regulatory intelligence on Paediatric regulation (EU and US) - Performed presentations on Pediatric Regulation in various internal meetings - Writing, review and submission of Paediatric Investigation Plans Show less
-
-